Related references
Note: Only part of the references are listed.Hypertrophic cardiomyopathy
Barry J. Maron et al.
LANCET (2013)
Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: The role of PRKAG2 mutation
Eduardo Back Sternick et al.
HEART RHYTHM (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao et al.
NATURE (2011)
Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation
Brendan P. Kelly et al.
PEDIATRIC CARDIOLOGY (2009)
Shared genetic causes of cardiac hypertrophy in children and adults
Hiroyuki Morita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Focal AF-ablation after pulmonary vein isolation in a patient with hypertrophic cardiomyopathy using cryothermal energy
Yves Van Belle et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2008)
AMPK: a metabolic gauge regulating whole-body energy homeostasis
Ricardo Lage et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-Activated protein kinase
Hasan O. Akman et al.
PEDIATRIC RESEARCH (2007)
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Bing Xiao et al.
NATURE (2007)
A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia
Sanjay K. Banerjee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
AMP-activated protein kinase in the heart - Role during health and disease
Michael Arad et al.
CIRCULATION RESEARCH (2007)
Characterization of the role of γ2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome
JK Davies et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the γ2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency
B Burwinkel et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome - Natural history
RT Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome
JS Sidhu et al.
CIRCULATION (2005)
Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy
M Arad et al.
CIRCULATION (2003)
Phenotypic diversity in hypertrophic cardiomyopathy
M Arad et al.
HUMAN MOLECULAR GENETICS (2002)
PRKAG2 cardiac syndrome:: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy
MH Gollob et al.
CURRENT OPINION IN CARDIOLOGY (2002)
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy
MH Gollob et al.
CIRCULATION (2001)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
MH Gollob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
E Blair et al.
HUMAN MOLECULAR GENETICS (2001)
Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant γ2 subunit of 5′-AMP-activated protein kinase, to human chromosome 7q36
TM Lang et al.
GENOMICS (2000)
Share Paper
